Publication Cover
Journal of Environmental Science and Health, Part A
Toxic/Hazardous Substances and Environmental Engineering
Volume 56, 2021 - Issue 14
161
Views
0
CrossRef citations to date
0
Altmetric
Research Article

In vivo effects of aflatoxin B1 and benzo[a]pyrene on the heart muscle of chicken embryos

, , , , , , , , , & show all
Pages 1490-1495 | Received 02 Feb 2021, Accepted 22 Nov 2021, Published online: 23 Dec 2021
 

Abstract

The purpose of the present study was to evaluate the effects of aflatoxin B1 (AFB1) and benzo[a]pyrene (BaP) on the heart muscle of chicken embryos of the broiler line Ross 308. The benzo[a]pyrene in the organic oil solution was injected in ovo on the 6th day of the incubation in doses of: 0.1, 0.5, and 1 mg/kg weight of eggs; the aflatoxin B1 in the organic oil solution was injected in ovo on the 6th day of the incubation into the yolk in doses of 80, 120 and 240 ng/kg weight of eggs. Multiple biochemical and hepatic parameters have been observed, including sodium, potassium, chloride, cholesterol, uric acid, total proteins, aminotransferase aspartate, and aminotransferase alanine. A low dose of AFB1 and BaP administered in ovo during early embryonic development had a significant impact on chicken embryonic development, as demonstrated by alterations in biochemical, mineral, and hepatic parameters.

Disclosure statement

No potential conflict of interest was reported by the authors.

Data availability statement

  1. The datasets generated during and/or analyzed during the current study are available in the Mendeley repository, https://data.mendeley.com//datasets/tx3tw29p62/1. .

  2. The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

  3. All data generated or analyzed during this study are included in this published article (and its supplementary information files).

Additional information

Funding

This work was financially supported by projects APVV-15-0543, APVV-16-0289, APVV-20-0218, VEGA 1/0038/19, VEGA 1/0539/18, and VEGA 1/0083/21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.